Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DHR

Danaher Corp

Mar 14 • 04:00PM ET

210.74

Dollar change +6.65
Percentage change 3.26	%

Healthcare • Diagnostics & Research • USA • NYSE

Peers: GE HON MMM ROK KEYS ABT TMO MTD BSX

| Held by: VTI VOO SPY IVV VTV XLV VIG VHT IWD IVE

Scroll to Statements

Index	S&P 500	P/E	39.85	EPS (ttm)	5.29	Insider Own	4.11%	Shs Outstand	719.10M	Perf Week	-0.63%
Market Cap	150.62B	Forward P/E	24.58	EPS next Y	8.57	Insider Trans	-0.14%	Shs Float	685.34M	Perf Month	4.23%
Income	3.90B	PEG	4.78	EPS next Q	1.62	Inst Own	81.44%	Short Float	1.19%	Perf Quarter	-10.07%
Sales	23.88B	P/S	6.31	EPS this Y	2.06%	Inst Trans	0.18%	Short Ratio	1.88	Perf Half Y	-22.52%
Book/sh	68.90	P/B	3.06	EPS next Y	12.29%	ROA	4.81%	Short Interest	8.17M	Perf Year	-16.74%
Cash/sh	2.91	P/C	72.48	EPS next 5Y	8.34%	ROE	7.57%	52W Range	196.80 - 281.70	Perf YTD	-8.19%
Dividend Est.	1.20 (0.57%)	P/FCF	28.44	EPS past 5Y	9.03%	ROI	5.91%	52W High	-25.19%	Beta	0.86
Dividend TTM	1.08 (0.51%)	Quick Ratio	1.05	Sales past 5Y	7.33%	Gross Margin	59.50%	52W Low	7.08%	ATR (14)	5.51
Dividend Ex-Date	Mar 28, 2025	Current Ratio	1.40	EPS Y/Y TTM	-17.25%	Oper. Margin	21.71%	RSI (14)	49.47	Volatility	2.64% 2.38%
Employees	63000	Debt/Eq	0.35	Sales Y/Y TTM	-13.50%	Profit Margin	16.33%	Recom	1.52	Target Price	266.00
Option/Short	Yes / Yes	LT Debt/Eq	0.33	EPS Q/Q	3.13%	Payout	20.42%	Rel Volume	0.91	Prev Close	204.09
Sales Surprise	1.44%	EPS Surprise	-0.81%	Sales Q/Q	2.08%	Earnings	Jan 29 BMO	Avg Volume	4.35M	Price	210.74
SMA20	1.36%	SMA50	-4.34%	SMA200	-14.65%	Trades		Volume	3,934,091	Change	3.26%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-14-25	Upgrade	Stifel	Hold → Buy	$260
Feb-03-25	Downgrade	Raymond James	Outperform → Mkt Perform
Dec-23-24	Initiated	Scotiabank	Sector Perform
Dec-19-24	Initiated	Guggenheim	Buy	$275
Dec-13-24	Upgrade	BofA Securities	Neutral → Buy	$290
Oct-31-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$285
Oct-01-24	Initiated	Stephens	Overweight	$315
Aug-28-24	Initiated	Wells Fargo	Equal Weight	$280
Jun-03-24	Resumed	Jefferies	Buy	$295
Apr-17-24	Upgrade	HSBC Securities	Hold → Buy	$280
Jan-24-24	Downgrade	Barclays	Overweight → Equal Weight	$240
Dec-18-23	Initiated	HSBC Securities	Hold
Dec-13-23	Resumed	Wolfe Research	Peer Perform
Dec-07-23	Downgrade	Goldman	Buy → Neutral	$215 → $205
Jul-19-23	Initiated	Raymond James	Outperform	$270
May-01-23	Initiated	SVB Securities	Outperform	$300
Apr-26-23	Downgrade	BofA Securities	Buy → Neutral	$310 → $250
Apr-18-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$275 → $285
Jan-05-23	Downgrade	Credit Suisse	Outperform → Neutral	$315 → $300
Dec-14-22	Initiated	Deutsche Bank	Buy	$310

Show Previous Ratings

Today 09:40AM	Chipotle upgraded, Charter initiated: Wall Streets top analyst calls (TipRanks)
Mar-14-25 04:20PM	Danaher Stock Has Fallen Far Enough. Buy It Now, Says Analyst. (Barrons.com)
Mar-13-25 08:01AM	Unlocking Intrinsic Value: Analysis of Danaher Corp (GuruFocus.com)
Mar-12-25 08:29AM	Heres Why Danaher Corporation Corp (DHR) Fell in Q4 (Insider Monkey)
Mar-11-25 05:02AM	Danaher (DHR): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
08:30AM	Loading…
Mar-10-25 08:30AM	Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System (PR Newswire)
Mar-07-25 11:43AM	Why Danaher Corporation (DHR) Is Plunging So Far in 2025? (Insider Monkey)
Mar-04-25 04:02AM	Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks (StockStory)
Feb-28-25 11:30AM	Danaher (DHR) Down 7.8% Since Last Earnings Report: Can It Rebound? (Zacks)
Feb-27-25 09:11AM	Jim Cramer to Danaher (DHR) Management: We Are Getting Restless (Insider Monkey)
Feb-25-25 04:15PM	Danaher to Present at TD Cowen Health Care Conference (PR Newswire)
01:49PM	Danaher Corporation (DHR): Among Bourgeon Capitals Top Stock Picks (Insider Monkey)
Feb-24-25 08:06AM	Heres What Will Drive Danaher Corporations (DHR) Above-Average Growth (Insider Monkey)
Feb-23-25 08:50AM	Is Danaher Corporation (DHR) the Best Scientific Instruments Stock to Buy Right Now? (Insider Monkey)
Feb-20-25 04:45PM	Danaher Announces Appointment of Charles Lamanna to Danaher Board (PR Newswire)
04:15PM	Loading…
04:15PM	Danaher Increases Quarterly Dividend (PR Newswire)
Feb-12-25 11:34AM	Is Danaher Corporation (DHR) The Best Manufacturing Stock To Buy Now? (Insider Monkey)
11:17AM	3 Healthcare Stocks Skating on Thin Ice (StockStory)
09:21AM	Why Danaher Corporation (DHR) is the Best Medical Device Stock to Buy (Insider Monkey)
Feb-09-25 04:26PM	Jim Cramer Slams Danaher (DHR): Bad Quarter, Smug Management (Insider Monkey)
Feb-08-25 03:17PM	Danaher Corporation (DHR): 'Sharp as a Tack People Who've Lost Their Way,' Says Jim Cramer (Insider Monkey)
Feb-07-25 09:50AM	Johnson Controls price target raised to $93 from $86 at RBC Capital (TipRanks)
Feb-05-25 11:22AM	Johnson Controls Stock Leads S&P Gainers on New CEO, Solid Q1 Results (Investopedia)
Feb-03-25 12:47PM	Is Danaher Corporation (DHR) the Best Cancer Stock to Buy According to Hedge Funds? (Insider Monkey)
11:33AM	Raymond James downgrades Danaher on murky growth outlook (Investing.com)
Feb-01-25 03:44AM	Why Danaher Corporation (DHR) Is Among the Best Long Term Low Risk Stocks to Buy Now (Insider Monkey)
Jan-31-25 04:47PM	Jim Cramer Says He's 'Extremely Disappointed' In Danaher Corporation (DHR) (Insider Monkey)
01:11PM	Danahers (NYSE:DHR) Q4 Sales Beat Estimates (StockStory)
07:31AM	Danaher price target lowered to $260 from $265 at Stifel (TipRanks)
02:15AM	Danaher Corp (DHR) Q4 2024 Earnings Call Highlights: Strategic Growth Amid Market Challenges (GuruFocus.com)
06:59AM	Loading…
Jan-30-25 06:59AM	Why Danaher Corp. (DHR) Crashed on Wednesday? (Insider Monkey)
12:14AM	Q4 2024 Danaher Corp Earnings Call (Thomson Reuters StreetEvents)
Jan-29-25 03:37PM	Analyst Report: Danaher Corporation (Morningstar Research) -9.73%
12:18PM	Danaher Stock Tanks 8.6% After Rare Earnings Miss--Is the Growth Story Cracking? (GuruFocus.com)
11:00AM	Danaher (DHR) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
10:20AM	Danaher Stock Falls the Most Since 2023. Why Earnings Were Such a Disappointment. (Barrons.com)
08:56AM	Danaher Had an Unusual Quarter. The Stock Is Down. (Barrons.com)
07:10AM	Danaher (DHR) Lags Q4 Earnings Estimates (Zacks)
06:56AM	Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag (Benzinga)
06:15AM	Danaher: Q4 Earnings Snapshot (Associated Press Finance)
06:13AM	Danaher Issues Revenue Outlook (RTT News)
06:00AM	Danaher Reports Fourth Quarter and Full Year 2024 Results (PR Newswire)
Jan-28-25 02:47PM	Why Are Hedge Funds Bullish on Danaher Corporation (DHR)? (Insider Monkey)
Jan-24-25 06:01AM	Danaher Corp: An Exploration into Its Intrinsic Value (GuruFocus.com)
Jan-23-25 08:54PM	Is Danaher Corporation (DHR) Among Billionaire Dan Loebs Top Stock Picks? (Insider Monkey)
11:26AM	Is Danaher Corporation (DHR) the Best Diversified Dividend Stock to Buy Now? (Insider Monkey)
Jan-22-25 10:00AM	Danaher (DHR) Earnings Expected to Grow: Should You Buy? (Zacks)
Jan-21-25 07:26AM	Aldevron Unveils Next-Generation Alchemy Cell-Free DNA Technology for Research Grade Applications (Business Wire)
Jan-17-25 06:01AM	Beyond Market Price: Uncovering Danaher Corp's Intrinsic Value (GuruFocus.com)
Jan-15-25 08:30AM	Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research (PR Newswire)
Jan-13-25 04:15PM	Danaher CEO to Comment on Financial Performance (PR Newswire)
Jan-10-25 06:01AM	Invest with Confidence: Intrinsic Value Unveiled of Danaher Corp (GuruFocus.com)
Jan-09-25 04:15PM	Danaher Announces Investment Partnership in Innovaccer Inc. (PR Newswire)
Jan-07-25 08:15AM	Danaher price target lowered to $285 from $305 at Citi (TipRanks)
Jan-06-25 04:15PM	Danaher to Present at J.P. Morgan Healthcare Conference (PR Newswire)
Jan-03-25 12:10PM	Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
06:46AM	Danaher price target lowered to $268 from $278 at Evercore ISI (TipRanks)
Jan-02-25 04:05PM	Danaher Schedules Fourth Quarter 2024 Earnings Conference Call (PR Newswire)
Dec-31-24 06:01AM	Beyond Market Price: Uncovering Danaher Corp's Intrinsic Value (GuruFocus.com)
Dec-28-24 04:15PM	Jim Cramer on Danaher Corporation (DHR): We Stuck With Danaher Because We Have Tremendous Respect For The Company (Insider Monkey)
04:15PM	Jim Cramer on Danaher Corporation (DHR): and#8216;We Stuck With Danaher Because We Have Tremendous Respect For The Company' (Insider Monkey)
Dec-26-24 06:35AM	Beyond Market Price: Uncovering Danaher Corp's Intrinsic Value (GuruFocus.com)
Dec-23-24 02:18PM	Jim Cramer Reports That Danaher Corporation (DHR)s China Core Revenue Dropped By A High-single-digit Percent In Q3 (Insider Monkey)
Dec-21-24 02:56AM	Cramer Criticizes Danaher (DHR) for Lackluster Performance and Unimpressive Guidance (Insider Monkey)
Dec-20-24 07:44PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Dec-15-24 02:04PM	Why Danaher Corporation (DHR) Is the Best Stock to Buy for the Long-Term According to Charles Akre? (Insider Monkey)
Dec-13-24 01:57PM	Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst (Benzinga)
Dec-12-24 06:02AM	Danaher Corp: An Exploration into Its Intrinsic Value (GuruFocus.com)
Dec-11-24 09:09AM	Heres Why Parnassus Growth Equity Fund Sold Danaher Corp. (DHR) (Insider Monkey)
Dec-10-24 04:15PM	Danaher Announces Quarterly Dividend (PR Newswire)
Nov-29-24 06:00AM	Navigating Market Uncertainty: Intrinsic Value of Danaher Corp (GuruFocus.com)
Nov-26-24 05:00PM	Danaher to Present at Evercore ISI HealthCONx Conference (PR Newswire)
Nov-22-24 02:28PM	Danaher Corp (NYSE:DHR): A Bullish Investment Perspective (Insider Monkey)
Nov-20-24 02:34PM	Analyst Report: Danaher Corporation (Morningstar Research)
Nov-19-24 09:59AM	Danaher Corporation (DHR) Highlighted Milestones in its 2024 Corporate Sustainability Report (Insider Monkey)
Nov-15-24 07:37PM	Analyst Report: Danaher Corporation (Morningstar Research)
Nov-14-24 06:00AM	Unlocking Intrinsic Value: Analysis of Danaher Corp (GuruFocus.com)
Nov-01-24 09:26AM	Heres Why Baron Health Care Fund Added Danaher Corporation (DHR) to its Portfolio (Insider Monkey)
Oct-31-24 08:00AM	Danaher Corp: An Exploration into Its Intrinsic Value (GuruFocus.com)
Oct-28-24 09:15AM	Danaher (DHR) Reliance on International Sales: What Investors Need to Know (Zacks)
Oct-26-24 06:15AM	Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks. (Motley Fool)
Oct-24-24 08:41AM	Danaher price target raised to $265 from $250 at Stifel (TipRanks)
Oct-23-24 04:25PM	Analyst Report: Danaher Corporation (Morningstar Research)
03:02AM	Danaher Corp (DHR) Q3 2024 Earnings Call Highlights: Resilient Performance Amidst Market Challenges (GuruFocus.com)
01:03AM	Decoding Danaher Corp (DHR): A Strategic SWOT Insight (GuruFocus.com)
12:21AM	Q3 2024 Danaher Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-22-24 05:25PM	Analyst Report: Danaher Corporation (Morningstar Research)
05:10PM	Jim Cramer on Danaher Corporation (DHR): Its A Very Important Position (Insider Monkey)
03:27PM	Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating (Benzinga)
09:30AM	Danaher (DHR) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:02AM	Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To Annual Guidance (Benzinga)
07:10AM	Danaher (DHR) Tops Q3 Earnings and Revenue Estimates (Zacks)
06:07AM	Danaher: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Danaher Reports Third Quarter 2024 Results (PR Newswire)
Oct-17-24 10:21AM	Cramer's Mad Dash: Danaher (CNBC TV)
09:15AM	Exploring Analyst Estimates for Danaher (DHR) Q3 Earnings, Beyond Revenue and EPS (Zacks)
Oct-16-24 08:00AM	Unlocking Intrinsic Value: Analysis of Danaher Corp (GuruFocus.com)
Oct-15-24 12:45PM	3 investable themes, categories outside of the AI trade (Yahoo Finance Video)
Oct-04-24 01:10PM	Is Danaher Corporation (NYSE:DHR) The Top Goldman Sachs Fund Manager Stock Pick? (Insider Monkey)
Oct-02-24 08:00AM	Danaher Corp: An Exploration into Its Intrinsic Value (GuruFocus.com)

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
King William	Former Officer	Mar 11 '25	Proposed Sale	207.14	64,697	13,401,340		Mar 11 04:03 PM
King William	Officer	Feb 21 '25	Proposed Sale	209.97	114,351	24,010,531		Feb 21 04:18 PM
Sabeti Pardis C	former Board of Directors	Feb 18 '25	Proposed Sale	204.28	4,337	885,953		Feb 18 01:04 PM
SPOON ALAN G	Director	Feb 07 '25	Option Exercise	59.34	3,928	233,088	121,068	Feb 10 05:00 PM
SPOON ALAN G	Director	Feb 07 '25	Sale	206.46	550	113,553	120,518	Feb 10 05:00 PM
SPOON ALAN G	Director	Feb 07 '25	Proposed Sale	206.46	550	113,553		Feb 07 03:34 PM
Ellis Brian W	Senior Vice President - GC	Jan 30 '25	Option Exercise	58.59	5,700	333,963	25,930	Jan 31 05:00 PM
Ellis Brian W	Senior Vice President - GC	Jan 30 '25	Sale	224.13	5,700	1,277,541	20,230	Jan 31 05:00 PM
Ellis Brian W	Officer	Jan 30 '25	Proposed Sale	224.13	5,700	1,277,542		Jan 30 12:56 PM
Raskas Daniel	SVP - Corporate Development	Nov 26 '24	Option Exercise	58.59	26,318	1,541,972	41,543	Nov 27 05:01 PM
Raskas Daniel	SVP - Corporate Development	Nov 26 '24	Sale	236.59	26,318	6,226,497	15,225	Nov 27 05:01 PM
Raskas Daniel	SVP - Corporate Development	Nov 25 '24	Sale	238.00	8,370	1,992,060	15,225	Nov 27 05:01 PM
Raskas Daniel	Officer	Nov 26 '24	Proposed Sale	236.59	26,318	6,226,496		Nov 26 04:40 PM
Raskas Daniel	Officer	Nov 25 '24	Proposed Sale	238.00	8,370	1,992,060		Nov 25 12:04 PM
Glenstone Foundation	See Remarks	Nov 05 '24	Proposed Sale	247.76	100,000	24,776,000		Nov 05 04:01 PM
Weidemanis Joakim	Former Director	Oct 23 '24	Proposed Sale	254.95	17,659	4,502,216		Oct 23 01:10 PM
Couchara Georgeann	SVP, Human Resources	Aug 26 '24	Sale	268.37	952	255,483	4,212	Aug 27 05:04 PM
Couchara Georgeann	Officer	Aug 26 '24	Proposed Sale	268.37	952	255,483		Aug 26 04:40 PM
Glenstone Foundation	See Remarks	Aug 13 '24	Proposed Sale	267.20	47,937	12,808,766		Aug 13 04:05 PM
Blair Rainer	President & CEO	Jul 31 '24	Sale	280.00	9,007	2,521,960	97,983	Aug 02 05:00 PM
FILLER LINDA	Director	Aug 01 '24	Option Exercise	59.34	3,928	233,088	45,077	Aug 02 05:00 PM
FILLER LINDA	Director	Aug 01 '24	Sale	279.50	3,928	1,097,876	41,149	Aug 02 05:00 PM
McGrew Matthew	EVP & Chief Financial Officer	Aug 01 '24	Option Exercise	62.85	16,172	1,016,410	45,579	Aug 02 05:00 PM
McGrew Matthew	EVP & Chief Financial Officer	Aug 01 '24	Sale	279.84	16,172	4,525,555	29,407	Aug 02 05:00 PM
McGrew Matthew	Officer	Aug 01 '24	Proposed Sale	279.84	16,172	4,525,555		Aug 01 04:28 PM
FILLER LINDA	Director	Aug 01 '24	Proposed Sale	279.50	3,928	1,097,876		Aug 01 12:27 PM
Blair Rainer	Officer	Jul 31 '24	Proposed Sale	280.00	9,007	2,521,960		Jul 31 04:26 PM
Ellis Brian W	Senior Vice President - GC	Jul 25 '24	Sale	275.16	9,600	2,641,536	20,230	Jul 26 05:03 PM
Raskas Daniel	SVP - Corporate Development	Jul 25 '24	Sale	270.51	14,507	3,924,352	23,595	Jul 26 05:03 PM
Zerhouni Elias A.	Director	Jul 15 '24	Option Exercise	52.56	3,289	172,870	37,483	Jul 16 05:01 PM
SCHWIETERS JOHN T	Director	Jul 15 '24	Option Exercise	52.56	3,289	172,870	19,808	Jul 16 05:00 PM
King William	SVP, Strategic Development	May 15 '24	Option Exercise	50.37	12,623	635,821	55,208	May 17 05:10 PM
Blair Rainer	President & CEO	May 16 '24	Sale	265.00	9,005	2,386,325	106,990	May 17 05:08 PM
Blair Rainer	President & CEO	May 14 '24	Option Exercise	59.91	19,085	1,143,435	135,080	May 15 05:00 PM
Blair Rainer	President & CEO	May 14 '24	Sale	255.00	19,085	4,866,675	115,995	May 15 05:00 PM
McGrew Matthew	EVP & Chief Financial Officer	May 10 '24	Option Exercise	61.25	25,174	1,541,794	45,338	May 13 05:01 PM
McGrew Matthew	EVP & Chief Financial Officer	May 10 '24	Sale	253.05	46,377	11,735,856	29,407	May 13 05:01 PM
SPOON ALAN G	Director	May 02 '24	Option Exercise	52.56	3,289	172,870	116,910	May 03 05:03 PM
SPOON ALAN G	Director	May 02 '24	Sale	243.58	708	172,455	116,202	May 03 05:03 PM
Weidemanis Joakim	Executive Vice President	Apr 25 '24	Option Exercise	58.48	22,433	1,311,882	112,845	Apr 26 05:00 PM
Weidemanis Joakim	Executive Vice President	Apr 25 '24	Sale	250.46	22,433	5,618,569	90,412	Apr 26 05:00 PM
Ellis Brian W	Senior Vice President - GC	Apr 24 '24	Sale	250.01	4,000	1,000,040	29,830	Apr 25 05:00 PM
Blair Rainer	President & CEO	Apr 24 '24	Option Exercise	59.91	38,170	2,286,870	154,165	Apr 25 05:00 PM
Blair Rainer	President & CEO	Apr 24 '24	Sale	249.22	47,175	11,756,725	115,995	Apr 25 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DHR

Danaher Corp

Upgrade your FINVIZ experience